Table of Contents
Wound Treatments in China Euromonitor International September 2009
List of Contents and Tables Sector Data Table 1 Sales of Wound
Treatments by Subsector: Value 2003-2008 Table 2 Sales of Wound Treatments
by Subsector: % Value Growth 2003-2008 Table 3 Wound Treatments Company
Shares by Value 2004-2008 Table 4 Wound Treatments Brand Shares by Value
2005-2008 Table 5 Forecast Sales of Wound Treatments by Subsector: Value
2008-2013 Table 6 Forecast Sales of Wound Treatments by Subsector: % Value
Growth 2008-2013 Amway (china) Co Ltd Strategic Direction Key
Facts Summary 1 Amway (China) Co Ltd: Key Facts Company Background
Production Competitive Positioning Summary 2 Amway (China) Co Ltd:
Competitive Position 2008 Bristol-Myers Squibb (shanghai) Trading Co
Ltd Strategic Direction Key Facts Summary 3 Bristol-Myers Squibb
(Shanghai) Trading Co Ltd: Key Facts Company Background Production
Summary 4 Bristol-Myers Squibb (Shanghai) Trading Co Ltd: Production
Statistics 2008 Competitive Positioning Summary 5 Bristol-Myers Squibb
(Shanghai) Trading Co Ltd: Competitive Position 2008 GlaxoSmithKline
(tianjin) Pharm Co Ltd Strategic Direction Key Facts Summary 6
GlaxoSmithKline (Tianjin) Pharm Co Ltd: Key Facts Company Background
Production Summary 7 GlaxoSmithKline (Tianjin) Pharm Co Ltd: Production
Statistics 2008 Competitive Positioning Summary 8 GlaxoSmithKline
(Tianjin) Pharm Co Ltd: Competitive Position 2008 Jiangzhong
Pharmaceutical Co Strategic Direction Key Facts Summary 9
Jiangzhong Pharmaceutical Co Ltd: Key Facts Company Background
Production Competitive Positioning Summary 10 Jiangzhong
Pharmaceutical Co Ltd: Competitive Position 2008 Sanjiu Enterprise
Group Strategic Direction Key Facts Summary 11 Sanjiu Enterprise
Group: Key Facts Company Background Production Competitive
Positioning Summary 12 Sanjiu Enterprise Group: Competitive Position
2008 Tianjin Tianshi Biological Development Co Ltd Strategic
Direction Key Facts Summary 13 Tianjin Tianshi Biological Development
Co Ltd: Key Facts Company Background Production Competitive
Positioning Summary 14 Tianjin Tianshi Biological Development Co Ltd:
Competitive Position 2008 Tibet Linzhi Qizheng Tibetan Medicine Fty
Strategic Direction Key Facts Summary 15 Tibet Linzhi Qizheng Tibetan
Medicine Fty: Key Facts Company Background Production Summary 16
Tibet Linzhi Qizheng Tibetan Medicine Fty: Production Statistics 2007
Competitive Positioning Summary 17 Tibet Linzhi Qizheng Tibetan Medicine
Fty: Competitive Position 2008 Wyeth Pharmaceutical Co Ltd Strategic
Direction Key Facts Summary 18 Wyeth Pharmaceutical Co Ltd: Key
Facts Company Background Production Summary 19 Wyeth
Pharmaceutical Co Ltd: Production Statistics 2008 Competitive
Positioning Summary 20 Wyeth Pharmaceutical Co Ltd: Competitive Position
2008 Xian Janssen Pharmaceutical Ltd Strategic Direction Key
Facts Summary 21 Xian Janssen Pharmaceutical Ltd: Key Facts Company
Background Production Competitive Positioning Summary 22 Xian
Janssen Pharmaceutical Ltd: Competitive Position 2008 Yunnan Baiyao Group
Co Ltd Strategic Direction Key Facts Summary 23 Yunnan Baiyao
Group Co Ltd: Key Facts Company Background Production Summary 24
Yunnan Baiyao Group Co Ltd: Production Statistics 2008 Competitive
Positioning Summary 25 Yunnan Baiyao Group Co Ltd: Competitive Position
2008 Executive Summary Growing Health Awareness and Disposable Incomes
Fuel Growth Vitamins and Dietary Supplements Lead Growth Amway Leads
Fragmented OTC Healthcare Chemists/pharmacies Lead But Direct Selling
Grows Fastest Steady Growth for Forecast Period Key Trends and
Developments Rising Health-consciousness and Self-medication
Convenience Becomes Increasingly Important Lifestyle Changes Shape
Growth Players Increasingly Focus on Specific Consumer Targets
Deep-rooted Tradition Impacts OTC Healthcare Territory Key Trends and
Developments East China Mid China North and Northeast China
Northwest China South China Southwest China Market Indicators
Table 7 Consumer Expenditure on Health Goods and Medical Services
2003-2008 Table 8 Life Expectancy at Birth 2003-2008 Market Data
Table 9 Sales of OTC Healthcare by Sector: Value 2003-2008 Table 10 Sales
of OTC Healthcare by Sector: % Value Growth 2003-2008 Table 11 Sales of
OTC Healthcare by Region: Value 2003-2008 Table 12 Sales of OTC Healthcare
by Region: % Value Growth 2003-2008 Table 13 OTC Healthcare Company Shares
by Value 2004-2008 Table 14 OTC Healthcare Brand Shares by Value
2005-2008 Table 15 Sales of OTC Healthcare by Distribution Format: %
Analysis 2003-2008 Table 16 Sales of OTC Healthcare by Sector and
Distribution Format: % Analysis 2008 Table 17 Forecast Sales of OTC
Healthcare by Sector: Value 2008-2013 Table 18 Forecast Sales of OTC
Healthcare by Sector: % Value Growth 2008-2013 Table 19 Forecast Sales of
OTC Healthcare by Region: Value 2008-2013 Table 20 Forecast Sales of OTC
Healthcare by Region: % Value Growth 2008-2013 Appendix OTC
Registration and Classification Vitamins & Dietary Supplements
Registration and Classification Self-medication and Preventative
Medicine Generics Switches Summary 26 OTC Healthcare Switches
2005-2007 Definitions Summary 27 Research Sources
|